Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancerMichael L. Beshiri, Kathleen Kelly, Aian Neil Alilin et al.|Stem Cells|2024Cited by 6
Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuitIlya S. Senatorov, Kathleen Kelly, Joel M. Bowman et al.|Cell Reports Medicine|2024Cited by 5
Tumor-derived biomarkers beyond antigen expression enhance efficacy of CD276/B7H3 antibody-drug conjugate in metastatic prostate cancerSupreet Agarwal, Kathleen Kelly, Lei Fang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
Abstract B051: PDX-derived and patient-derived prostate cancer organoids as a clinically relevant platform for translational researchMichael L. Beshiri, Kathleen Kelly, Caitlin M. Tice et al.|Cancer Research|2018Cited by 0